AXGN
Axogen Inc.

1,355
Loading...
Loading...
News
all
press releases
Does AxoGen (AXGN) Have the Potential to Rally 53.1% as Wall Street Analysts Expect?
The mean of analysts' price targets for AxoGen (AXGN) points to a 53.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·11d ago
News Placeholder
More News
News Placeholder
Why Is Axogen Stock Down 15% In Pre-Market Today?
The stock tumbled after the company announced that the U.S. FDA pushed the date of the decision regarding approval for Avance Nerve Graft by three months.
Stocktwits·14d ago
News Placeholder
Wall Street Analysts Predict a 76.37% Upside in AxoGen (AXGN): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 76.4% in AxoGen (AXGN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks·27d ago
News Placeholder
AxoGen (AXGN) Beats Q2 Earnings and Revenue Estimates
AxoGen (AXGN) delivered earnings and revenue surprises of +100.00% and +7.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Waters (WAT) Surpasses Q2 Earnings and Revenue Estimates
Waters (WAT) delivered earnings and revenue surprises of +0.68% and +3.63%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Will PROCEPT BioRobotics Corporation (PRCT) Report Negative Earnings Next Week? What You Should Know
PROCEPT BioRobotics (PRCT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·1mo ago
News Placeholder
AxoGen (AXGN) Earnings Expected to Grow: Should You Buy?
AxoGen (AXGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·1mo ago
News Placeholder
AxoGen (AXGN) Loses 25.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Zacks·4mo ago
News Placeholder
AxoGen Q2 Earnings and Revenues Beat Estimates
AxoGen (NASDAQ: AXGN) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.05 per share. This compares to loss of $0.03 per share a year ago...
Benzinga·1y ago
News Placeholder
Axogen (AXGN, $8.07) Aroon Indicator entered a Downtrend on March 28, 2024.
For the last three days, A.I.dvisor has detected that AXGN's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
Tickeron - Stocks·1y ago

Latest AXGN News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.